Medline to acquire surgical solutions business from Ecolab, Inc.

Press releases may be edited for formatting or style | May 02, 2024 Business Affairs
Medline announced today that it has entered into a definitive agreement to acquire the global surgical solutions business of Ecolab, Inc., including the industry-leading Microtek product lines. Once closed, the acquisition will provide Medline with innovative sterile drape solutions for surgeons, patients, and operating room equipment, as well as Ecolab’s fluid temperature management system.

Medline looks forward to building on the deep legacy of the Microtek brand by combining the reputation for innovation and reliability in these categories with Medline’s expansive commercial footprint, market-leading supply chain capabilities, and robust manufacturing expertise.

“We are pleased to have the opportunity to acquire a leading portfolio of operating room products with such a strong reputation for protecting patients and healthcare workers,” said Jim Pigott, president and chief operating officer for Medline. “With our commercial capability and focus on operational excellence, we believe that Medline is best positioned to grow this critical business and provide enhanced services to support our customers. This acquisition brings us proven innovation, expanded service offerings, and a shared legacy of highest quality products. As we embark on this exciting new chapter, we are committed to a seamless integration for both employees and customers.”

This acquisition also creates an opportunity to add design and development capabilities to Medline’s portfolio to support OEM customers. With these new capabilities, Medline will be able to provide complementary products to protect both patients and cutting-edge equipment in the surgical suites.

“We look forward to welcoming Ecolab surgical solutions team members to the Medline family and together continuing to serve our customers with innovation, quality, and a shared focus on making healthcare run better,” said Pigott.

Subject to standard closing conditions and regulatory approvals, the transaction is expected to close in the second half of 2024.

You Must Be Logged In To Post A Comment